Andrew M Redmond (Andrew Redmond)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Listeria Monocytogenes

Stem Cell Transplantation

Top Venues

The Journal of antimicrobial chemotherapy

Internal medicine journal

This page only lists publications with an associated author ORCID identifier.

Publications

Joshua Sheehy, Ashleigh P Scott, Andrea S Henden, Glen A Kennedy, Andrew M Redmond, Adam G Stewart
Low rates of complications and β-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapy. The Journal of antimicrobial chemotherapy 79 (8) (2024)
Joshua Sheehy, Ashleigh P Scott, Andrea S Henden, Glen A Kennedy, Andrew M Redmond, Adam G Stewart
Low rates of complications and β-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapy. The Journal of antimicrobial chemotherapy (2024)
Joseph Chung, Kate L McCarthy, Andrew M Redmond, Jason Butler, Ashleigh P Scott, Adam G Stewart
Listeria monocytogenes brain abscess as a late complication of allogeneic haemopoietic stem cell transplantation. Internal medicine journal 51 (6) (2021)
Craig Haifer, Colleen R Kelly, Sudarshan Paramsothy, David Andresen, Lito E Papanicolas, Genevieve L McKew, Thomas J Borody, Michael Kamm, Samuel Paul Costello, Jane M Andrews, Jacob Begun, Hiu Tat Chan, Susan J Connor, Simon Ghaly, Paul Dr Johnson, Daniel A Lemberg, Ramesh Paramsothy, Andrew M Redmond, Harsha Sheorey, David van der Poorten, Rupert W L Leong
Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice. Gut 69 (5) (2020)